Theme: An insight into Advancing New methods of Cancer Diagnostics

Cancer Diagnostics 2017

Cancer Diagnostics 2017

Conferenceseries LLC invites all the participants from all over the world to attend “2nd Cancer Diagnostics Conference and Expo” during May 08-10, 2017 at Barcelona, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Cancer Diagnostics 2017 is the very special conference among the past Oncology Conferences.

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncology Societies, European Oncology Conferences, and American Oncology Society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Conference Series LLC, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

The following are the scientific sessions has been designed for the upcoming Cancer Diagnostics Conference.

Track 1:  Cancer Diagnostics Market:

Advanced diagnostics technologies have achieved a reduction of 30% in reduction due to breast cancer. Hence, the imaging sector in the global Oncological diagnostics market will continue its everlasting in the foreseeable future. The world-wide Cancer Diagnostics Market can be segmented into blood cancer, kidney cancer, breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, lung cancer, and liver cancer. The global cancer diagnostics market is mostly driven by enhancing the demand for lung cancer and breast cancer diagnosis. The Pulmonary cancer segment is leading the market, as it is the very popular type of cancer.  Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.

Track 2:  Cancer Diagnostics Types:

Mammogram is used to image and X-ray of the Breast. While screening mammograms are routinely administered to detect breast cancer in women who has no apparent signs, diagnostic systems are used after suspicious results on a screening mammogram has some symptoms of breast cancer alert the Oncologist to check that tissue.

An ultrasound wand is inserted in vagina and to see at the ovaries. An ultrasound produces sound waves that induces imaging of the ovaries, including cysts, and Oocytes. Researchers are currently studying whether this test can help with early detection of ovarian cancer.

A breast biopsy is a test that cut tissue fluid from the breast. The removed cells are tested under a microscope and later checked for whether there is breast cancer. Conferenceseries LLC organizes large number of Cancer Conferences globally across the Cancer associations and Cancer Research Organizations

Track 3: Cancer Screening Tests:

Prostate screening tests consists of Digital rectal exam (DRE) and Prostate-specific antigen (PSA) test.

Screening increases the capacity of detecting certain cancers early when they are most likely to be curable. Learn what screening tests the American Cancer associations suggests, when you should have them, and how they are covered under some types of cancer therapies.

Mammograms are used to analyses breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences.

Track 4: Organ Specific Cancer:

Brain and spinal cord tumours may be either benign (not cancer) or malignant (cancer).Both benign and malignant tumours cause signs and symptoms and need treatment. Benign brain and spinal cord tumours grow and press on nearby areas of the brain but rarely spread into other parts of the brain. Malignant brain and spinal cord tumours are likely to grow quickly and spread into other parts of the brain. The bones around the nasal cavity have small hollow spaces in them called paranasal sinuses. These sinuses affect the sound and tone of voice. The exact causes of nasal and sinus cancers are not known. Cancers that are known collectively as head and neck cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). The most dangerous form of skin cancer is these cancerous growths develop once unrepaired DNA damage to skin cells most frequently caused by ultraviolet radiation from sunshine or tanning beds triggers mutations genetic defects that lead the skin cells to multiply rapidly and form malignant tumors. Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin. Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Pulmonary metastases of renal cell carcinoma (RCC) are associated with poor prognosis. Inhalation therapy with interleukin-2 (IL-2) is thus an appealing method for palliation. Carcinoma of the thyroid gland is an uncommon cancer but is the most common malignancy of the endocrine system. Differentiated tumours (papillary or follicular) are highly treatable and usually curable. Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer. Most cases of HCC are secondary to either a viral hepatitis infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of liver cirrhosis). Reproductive cancers start in the organs related to reproduction. These organs are located in the pelvis. The pelvis is the area in the lower belly between the hip bones.

Track 5: Approaches in Cancer Therapy

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumor angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and Oncology Conferences

Track 6: Cancer Treatment and Therapies

The branch of medicine that deals with the diagnosis and treatment of injury, deformity, and disease by the use of instruments. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Refractive surgery is the term used to describe surgical procedures that correct common vision problems (nearsightedness, farsightedness, astigmatism and presbyopia) to reduce your dependence on prescription eyeglasses and/or contact lenses. Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. Hyperthermia is elevated body temperature due to failed thermoregulation that occurs when a body produces or absorbs more heat than it dissipates.

Track 7: Cancer Biomarkers

Biomarkers play a significant role in cancer prognosis, diagnosis and treatment of cancers these days. There are many types of cancers which are hard to even diagnose. The latest designed biomarkers and their applications provide a great advantage in these cases. Cancer Epidemiology, treatment and latest research is greatly relayed on the biomarkers.

The major types of cancers in which biomarkers are widely being used are breast cancer, lung cancer, prostate cancer and blood cancer.

Track 8: Cancer Immunotherapy

Immunotherapy is treatment that uses certain parts of a person’s immune system to fight diseases such as cancer. This can be done in a couple of ways: Own immune system stimulation, Biological therapy or biotherapy. These advances in cancer immunotherapy are the result of long-term investments in basic research on the immune system—research that continues today. Additional research is currently under way to: understand why immunotherapy is effective in some patients but not in other’s who have the same cancer, expand the use of immunotherapy to more types of cancer, increase the effectiveness of immunotherapy by combining it with other types of cancer treatment, such as targeted therapy, chemotherapy, and radiation therapy.

Track 9: Recent Diagnostics Technologies

An accurate and full knowledge on cancer diagnosis is the first step in developing an individualized cancer treatment strategy. When you first visit hospital, we will perform a complete array of diagnostic tests to accurately confirm your disease and plan your personal treatment. Diagnostic testing involves tests and procedures to confirm the disease and identify the tumor type, location, extent and stage. Its multidisciplinary approach allows readers to keep up-to-date with challenges and enhancement in their own as well as related fields. Cancer conferences also focused on these topics.

Track 10: Oncologists Meet

Oncologists are doctors who specialize in treating people with cancer. They are responsible for the care of a patient from the moment of a cancer diagnosis throughout the course of the disease. A medical oncologist specializes in treating cancer with chemotherapy such as targeted therapy and oral (in pill form) chemotherapy. A surgical oncologist specializes in the removal of the tumour and surrounding tissue during an operation. And a radiation oncologist specializes in treating cancer with radiation therapy (the use of high-energy x-rays or other particles to kill cancer cells).

Track 11: Entrepreneurs Investment Meet

Conferenceseries LLC invites all the participants across the globe to attend the "2nd Cancer Diagnostics Conference and Expo” slated on May 08-10, 2017 at Barcelona, Spain

Cancer Diagnostics 2017 directs towards addressing main issues as well as future strategies of Cancer. This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumor immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Cancer Diagnostics 2017 will also provide the three days of discussions on methods and strategies related to management and quality improvement of Diagnostics device developing and Cancer Research and as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, leukemia, blood cancer, cervical cancer, colon-rectum cancer, pediatric cancer, surgical cancer, Prostate cancer, thyroid cancer.

According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increase in the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Nearly 60% of the world’s total new cases occur in the Africa, Asia and Central and South America regions. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it.

OMICS International along with its subsidiary Conferenceseries LLC  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. OMICS International hosts numerous Cancer Conferences, Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend?

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists community, oncology society, European oncology conferences, American oncology society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Target Audience:

Oncologists

Radiologists

Pathologists

Hematologists

Academicians

Research Scholars

Students

Hematology Associations & Societies

Business Entrepreneurs

Software Developing Companies

Medical Devices Companies

Biomedical Companies

Biotechnology Companies

Data Management Companies

Cancer Diagnostics 2016

Cancer Diagnostics 2016: Past Conference Report

Conferenceseries LLC hosted the “Cancer Diagnostics Conference and Expo” during June 13-15, 2016 at Holiday Inn Aurelia Hotel, Rome, Italy,

The conference was focused on Cancer Diagnostics and research in developing new methods of diagnostic studies with the theme “Enhancing innovations in Cancer Diagnosis and treatment”. A series of invited lectures by Keynote Speakers and Honorable Guest on the scientific sessions which include: Cancer Diagnostics Market, Cancer Diagnostics Types, Cancer Screening Tests, Approaches in Cancer Therapy, Predictive Cancer Biomarkers, Cancer Genomics and Epigenetics, Cancer Treatment, Recent Diagnostics Technologies.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Diana Anderson, University of Bradford, United Kingdom.

Tibor Tot, Central Hospital Falun, Sweden.

Feng Yan, Nanjing Medical University Cancer Hospital and Jiangsu Cancer Hospital, China

Best Poster Awardees:

Majed Al Fayi, University of Liverpool, London, UK.

Julia Alejandra Pezuk, Hospital Sirio-Libanes, Brazil

Ramos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Brazil

OMICS International offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with OMICS International and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Diagnostics 2016, OMICS International would like to announce the commencement of the “2nd Cancer Diagnostics Conference and Expo” to be held during May 08-10, 2017 Barcelona, Spain. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Research.

For More details: http://cancerdiagnostics.conferenceseries.com/

Let us meet again @ Cancer Diagnostics 2017


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date May 8-10, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations